Publications

Search our bibliography using the filters on the right-hand side.

Displaying 251 through 300 of 508 publications.

Vass CM, Wright S, Burton M, Payne K. Scale heterogeneity in healthcare discrete choice experiments: a primer. Patient. 2018 Apr;11(2):167-73. doi: 10.1007/s40271-017-0282-4

Poulos C, Curran D, Anastassopoulou A, De Moerlooze L. German travelers' preferences for travel vaccines assessed by a discrete choice experiment. Vaccine. 2018 Feb 8;36(7):969-78.

Vass C, Rigby D, Payne K. Investigating the heterogeneity in women's preferences for breast screening: does the communication of risk matter? Value Health. 2018 Feb;21(2018):219-28. doi: 10.1016/j.jval.2017.07.010

Lewis MA, Stine A, Paquin RS, Mansfield C, Wood D, Rini C, Roche MI, Powell CM, Berg JS, Bailey, Jr DB. Parental preferences toward genomic sequencing for non-medically actionable conditions in children: a discrete-choice experiment. Genet Med. 2018 Feb;20(2):181-9. doi: 10.1038/gim.2017.93

Cunningham NA, Abhyankar P, Cowie J, Galinksy J, Methven K. Regenerative medicine: stroke survivor and carer views and motivations towards a proposed stem cell clinical trial using placebo neurosurgery. Health Expect. 2018 Feb;21(1):367-78. doi: 10.1111/hex.12632

Ikenwilo D, Heidenreich S, Ryan M, Mankowski C, Nazir J, Watson V. The best of both worlds: an example mixed methods approach to understand men's preferences for the treatment of lower urinary tract symptoms. Patient. 2018 Feb;11(1):55-67. doi: 10.1007/s40271-017-0263-7

Heidenreich S, Watson V, Ryan M, Phimister E. Decision heuristic or preference? Attribute non-attendance in discrete choice problems. Health Econ. 2018 Jan;27(1):157-71. doi: 10.1002/hec.3524

Poulos C, Kinter E, van Beek J, Christensen K, Posner J. Preferences of patients with multiple sclerosis for attributes of injectable multiple sclerosis treatments in the United Kingdom and France. Int J Technol Assess Health Care. 2018 Jan;34(4):425-33. doi: 10.1017/S0266462318000491

Hauber AB, Mange B, Price MA, Wolin D, Bensink M, Kaye JA, Chandler D. Administration options for pegfilgrastim prophylaxis: patient and physician preferences from a cross-sectional survey. Support Care Cancer. 2018 Jan;26(1):251-60. doi: 10.1007/s00520-017-3841-2

Postmus D, Richard S, Bere N, van Valkenhoef G, Galinsky J, Low E, Moulon I, Mavris M, Salmonsson T, Flores B, Hillege H, Pignatti F. Individual trade‐offs between possible benefits and risks of cancer treatments: results from a stated preference study with patients with multiple myeloma. Oncologist. 2018 Jan;23(1):44-51. doi: 10.1634/theoncologist.2017-0257

Dundas SJ, von Haefen RH, Mansfield C. Recreation costs of endangered species protection: evidence from Cape Hatteras National Seashore. Marine Resource Economics. 2018 Jan;33(1):1-25. doi: 10.1086/694752

Tsuchiya A, Watson V. Re-thinking “the different perspectives that can be used when eliciting preferences in health". Health Econ. 2017 Dec;26(12):e103-7. doi: 10.1002/hec.3480

Krucien N, Watson V, Ryan M. Is best-worst scaling suitable for health state valuation? A comparison with discrete choice experiments. Health Econ. 2017 Dec;26(12):e1-e16. doi: 10.1002/hec.3459

Mansfield C, Sikirica MV, Pugh A, Poulos CM, Unmuessig V, Morano R, Martin AA. Patient preferences for attributes of type 2 diabetes mellitus medications in Germany and Spain: an online discrete-choice experiment survey. Diabetes Ther. 2017 Dec;8(6):1365-78. doi: 10.1007/s13300-017-0326-8

Mansfield C, Masaquel A, Sutphin J, Weiss E, Gutierrez M, Wilson J, Boeri M, Li J, Reyes C. Patients' priorities in selecting chronic lymphocytic leukemia treatments. Blood Adv. 2017 Nov 14;1(24):2176-85. doi: 10.1182/bloodadvances.2017007294

Mansfield C, Gebben D, Sutphin J, Tepper SJ, Schwedt TJ, Sapra S, Shah N. Patient preferences for preventive migraine treatments: a discrete-choice experiment. Poster presented at the 2017 AMCP NEXUS; October 18, 2017. Dallas, TX. [abstract] J Manag Care Pharm. 2017 Oct; 23(10-a):S55.

Hifinger M, Hiligsmann M, Ramiro S, Watson V, Berghea F, Pentek M, Keat A, Severens JL, Fautrel B, Boonen A. Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs: a discrete choice experiment among rheumatologists. RMD open. 2017 Sep 4;3(2):E000453. doi: 10.1136/rmdopen-2017-000453

Hauber AB, Obi EN, Price MA, Whalley D, Chang CL. Quantifying the relative importance to patients of avoiding symptoms and outcomes of heart failure. Curr Med Res Opin. 2017 Sep;33(11):2027-38. doi: 10.1080/03007995.2017.1355782

Liede A, Mansfield CA, Metcalfe KA, Price MA, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Snyder C, Lynch HT, Friedman S, Amelio J, Posner J, Narod SA, Lindeman GJ, Evans DG. Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment. Breast Cancer Res Treat. 2017 Sep;165(2):433-44. doi: 10.1007/s10549-017-4332-3.

Vass CM, Payne K. Using discrete choice experiments to inform the benefit-risk assessment of medicines: are we ready yet? Pharmacoeconomics. 2017 Sep;35(9):859-66. doi: 10.1007/s40273-017-0518-0.

Cleland JA, Johnston P, Watson V, Krucien N, Skatun D. What do UK medical students value most in their careers? A discrete choice experiment. Med Educ. 2017 Aug;51(8):839-51. doi: 10.1111/medu.13257

Mansfield C, Bullok KE, Fuhs JV, Kahle-Wrobleski K, Tockhorn-Heidenreich A, Andrews JS, DiBenedetti DB, Matthews BR, Darling JC, Siemers ER, Hauber AB. The patient voice: exploring treatment preferences in participants with mild cognitive concerns to inform regulatory decision-making. Poster presented at the 2017 Alzheimer’s Association International Conference; July 19, 2017. London, United Kingdom.

Liu X, Hannum E. Early poverty exposure predicts young adult educational outcomes in China. China Econ Rev. 2017 Jul;44:79-97.

Hiligsmann M, Dellaert BG, Dirksen CD, Watson V, Bours S, Goemaere S, Reginster JY, Roux C, McGowan B, Silke C, Whelan B, Diez-Perez A, Torres E, Papadakis G, Rizzoli R, Cooper C, Pearson G, Boonen A. Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment. Rheumatology. 2017 Jul 1;56(7):1167-76. doi: 10.1093/rheumatology/kex071

Mansfield C, Thomas N, Gebben D, Lucas M, Hauber AB. Preferences for multiple sclerosis treatments: using a discrete-choice experiment to examine differences across subgroups of US patients. Int J MS Care. 2017 Jul;19(4):172-83. doi: 10.7224/1537-2073.2016-039

Watson V, Becker F, de Bekker-Grob E. Discrete choice experiment response rates: a meta-analysis. Health Econ. 2017 Jun;26(6):810-7. doi: 10.1002/hec.3354

Mansfield CA, Boeri M, Reyes C, Masaquel AS, Sutphin JN, Li J. How can we assess the impact of cost on patient treatment preferences in CLL treatment? Poster presented at the 2017 ISPOR 22nd Annual International Meeting; May 22, 2017. Boston, MA. [abstract] Value Health. 2017 May; 20(5):A118.

Myers K, McNair D, Tomasi T, Schneider J. Assessing the validity of stated preference data using follow-up questions.. In: McFadden D, Train K, editors. Contingent valuation of environmental goods: a comprehensive critique. Northampton: MA. Edward Elgar Publishing, Inc; 2017. p.252-69. doi: 10.4337/9781786434692

Myers K, Parsons G, Train K. Inadequate response to frequency of payments in contingent valuation of environmental goods. In: McFadden D, Train K, editors. Contingent valuation of environmental goods: a comprehensive critique. Northampton: MA. Edward Elgar Publishing, Inc; 2017. p.43-57. doi: 10.4337/9781786434692

Parsons G, Myers K. Fat tails and truncated bids in contingent valuation: an application to an endangered shorebird species. In: McFadden D, Train K, editors. Contingent valuation of environmental goods: a comprehensive critique. Northampton: MA. Edward Elgar Publishing, Inc; 2017. p.17-42. doi: 10.4337/9781786434692

Vass C, Rigby D, Payne K. The role of qualitative research methods in discrete choice experiments. Med Decis Making. 2017 Apr;37(3):298-313. doi: 10.1177/0272989X16683934

Finkelstein EA, Mansfield C, Wood D, Rowe B, Chay J, Ozdemir S. Trade-offs between civil liberties and national security: a discrete choice experiment. Contemp Econ Policy. 2017 Apr;35(2):292-311. doi: 10.1111/coep.12188

Rojas Smith L, Clayton ML, Woodell C, Mansfield C. The role of patient navigators in improving caregiver management of childhood asthma. 2017. doi: 10.3768/rtipress.2017.rr.0030.1704

Liu X, Behrman JR, Stein AD, Adair LS, Bhargava SK, Borja JB, da Silveira MF, Horta BL, Martorell R, Norris SA, Richter LM, Sachdev HS. Prenatal care and child growth and schooling in four low- and medium-income countries. PLoS One. 2017 Feb 3;12(2):e0171299. doi: 10.1371/journal.pone.0171299

Hifinger M, Hiligsmann M, Ramiro S, Watson V, Severens JL, Fautrel B, Uhlig T, van Vollenhoven R, Jacques P, Detert J, Canas da Silva J, Scire CA, Berghea F, Carmona L, Pentek M, Keat A, Boonen A. Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: a discrete choice experiment among European rheumatologists. Ann Rheum Dis. 2017 Jan;76(1):126-32. doi: 10.1136/annrheumdis-2016-209202

Hifinger M, Hiligsmann M, Ramiro S, Severens JL, Fautrel B, Watson V, Boonen A. Patient's preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologists. Rheumatology. 2017 Jan;56(1):68-76. doi: 10.1093/rheumatology/kew328

Mansfield C, Masaquel A, Sutphin J, Weiss ES, Gutierrez ME, Wilson J, Li J, Reyes C. What do patients prioritize in selecting chronic lymphocytic leukemia (CLL) treatments? Presented at the 58th American Society of Hematology (ASH) Annual Meeting and Exposition; December 5, 2016. San Diego, CA. [abstract] Blood. 2016 Dec 2; 128(22):1239. doi: 10.1182/blood.V128.22.1239.1239

Mankowski C, Ikenwilo D, Heidenreich S, Ryan M, Nazir J, Newman C, Watson V. Men's preferences for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: a discrete choice experiment. Patient Prefer Adherence. 2016 Nov 24;10:2407-17. doi: 10.2147/PPA.S112161

Poulos C, Standaert B, Sloesen B, Hauber AB. What motivates mothers to pay for a vaccine against children's diarrhea? Preferences for vaccines against children's diarrheal illness among mothers in Poland and Hungary. Poster presented at the 2016 ISPOR 19th Annual European Congress; October 31, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A419.

Poulos C, Curran D, Anastassopoulou A, De Moerlooze L. German travelers' preferences for vaccines against travel-related illnesses. Poster presented at the 2016 ISPOR 19th Annual European Congress; October 31, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A419-20.

Mansfield C, Srinivas S, Chen C, Hauber AB, Hariharan S, Matczak E, Sandin R. The effect of information on preferences for treatments of metastatic renal cell carcinoma. Curr Med Res Opin. 2016 Nov;32(11):1827-38. doi: 10.1080/03007995.2016.1211521

Kenter JO, Bryce R, Christie M, Cooper N, Hockley N, Irvine KN, Fazey I, O'Brien L, Orchard-Webb J, Ravenscroft N, Raymond CM, Reed MS, Tett P, Watson V. Shared values and deliberative valuation: future directions. Ecosyst Serv. 2016 Oct;21(Part B):358-71. doi: 10.1016/j.ecoser.2016.10.006

Kenter JO, Jobstvogt N, Watson V, Irvine KN, Chrisstie M, Bryce R. The impact of information, value-deliberation and group-based decision-making on values for ecosystem services: integrating deliberative monetary valuation and storytelling. Ecosyst Serv. 2016 Oct;21(Part B):270-90. doi: 10.1016/j.ecoser.2016.06.006

Mamounas E, Poulos C, Goertz HP, Gonzalez JM, Pugh A, Antao V. Neoadjuvant systemic therapy for breast cancer: factors influencing surgeons' referrals. Ann Surg Oncol. 2016 Oct;23(11):3510-7. doi: 10.1245/s10434-016-5296-y

Hauber AB, Obi EN, Price MA, Whalley D, Chang CL. Patients' self-reported value of avoiding key heart failure outcomes differs based on disease knowledge. Poster presented at the 2016 HFSA 20th Annual Scientific Meeting; September 17, 2016. Orlando, FL.

Galinksy J, Richard S, Morris M. Myeloma patients' self-reported experiences of care and treatment. Cancer Nurs Pract. 2016 Sep 14;15(7):22-6. doi: 10.7748/cnp.2016.e1341

Wakefield JR, Myers K. Social cost benefit analysis for deep sea minerals mining. Mar Policy. 2016 Jun 22. doi: 10.1016/j.marpol.2016.06.018

Vass C, Gray E, Payne K. Discrete choice experiments of pharmacy services: a systematic review. Int J Clin Phar. 2016 Jun;38(3):620-30. doi: 10.1007/s11096-015-0221-1

Mansfield C, Ekwueme DU, Tangka FKL, Brown DS, Smith JL, Guy, Jr GP, Li C, Hauber AB. Preferences for colorectal cancer screening: a latent class analysis. Poster presented at the 2016 Academy Health Annual Research Meeting; June 2016. Boston, MA.

Vass CM, Payne K. What is health economics? Problematising value in stratified medicine. Presented at the Value, Context and Narrative in Medical Epistemology and Health Care Practice Conference; May 4, 2016. Oxford, United Kingdom.